...
机译:Nedaplatin Plus Docetaxel与Cisplatin Plus Docetaxel作为肺部晚期鳞状细胞癌的一线化学疗法 - 多中心,开放标签,随机,第三阶段试验
Shanghai Lung Cancer Center Shanghai Chest Hospital Shanghai Jiao Tong University;
Shanghai Lung Cancer Center Shanghai Chest Hospital Shanghai Jiao Tong University;
Department of Respiratory Xiangya Hospital Central South University;
Department of Respiratory Xijing Hospital the First Affiliated Hospital of the Fourth Military;
Division of Thoracic Tumor Tongji Hospital Tongji Medical College of Huazhong University of;
Department of Respiratory Nanjing Military General Hospital;
Division of Thoracic Tumor the First Affiliated Hospital Zhejiang University;
Department of Medical Oncology Zhejiang Cancer Hospital;
Department of Medical Oncology Union Hospital Tongji Medical College of Huazhong University of;
Division of Thoracic Tumor Henan Cancer Hospital Zhengzhou University;
Division of Thoracic Tumor Beijing Cancer Hospital Beijing University;
Division of Thoracic Tumor Guangxi Cancer Hospital;
Division of Thoracic Tumor Beijing Chest Hospital Capital Medical University;
Cisplatin; Docetaxel; Nedaplatin; Randomized controlled trial; Phase III; Squamous cell lung carcinoma;
机译:Nedaplatin Plus Docetaxel与Cisplatin Plus Docetaxel作为肺部晚期鳞状细胞癌的一线化学疗法 - 多中心,开放标签,随机,第三阶段试验
机译:MA 03.03 Nedaplatin Plus Docetaxel与Cisplatin Plus Docetaxel作为肺癌晚期鳞状细胞癌的一线化学疗法
机译:相较于多西他赛加顺铂和贝伐单抗方案,长春瑞滨加顺铂和贝伐单抗,多西他赛加吉西他滨和贝伐单抗的序贯给药作为晚期或转移性非鳞状非小细胞肺癌一线治疗的多西他赛方案希腊肿瘤研究小组(HORG)
机译:培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌(TFINE-0904):开放标签随机第三阶段试验
机译:多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌(TFINE-0904):开放标签,随机,第三阶段试验